Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | |
| Sales | 55,917 | 37,526 | 21,047 |
| Cost of Goods | 24,898 | 17,763 | 9,803 |
| Gross Profit | 31,019 | 19,764 | 11,244 |
| Operating Expenses | 31,845 | 26,279 | 21,358 |
| Operating Income | 72 | -5,753 | -9,310 |
| Interest Expense | 2,224 | 1,163 | 577 |
| Other Income | -138 | -20 | 76 |
| Pre-tax Income | -2,290 | -6,936 | -9,811 |
| Income Tax | 264 | 23 | -76 |
| Net Income Continuous | -2,554 | -6,959 | -9,735 |
| Net Income | $-2,554 | $-6,959 | $-9,735 |
| EPS Basic Total Ops | -1.47 | -2.89 | -1.13 |
| EPS Basic Continuous Ops | -0.59 | -1.72 | -0.90 |
| EPS Diluted Total Ops | -1.47 | -2.89 | -1.13 |
| EPS Diluted Continuous Ops | -0.59 | -1.72 | -0.90 |
| EBITDA(a) | $3,801 | $-2,991 | $-7,367 |